127 related articles for article (PubMed ID: 16801910)
1. [How to treat well differentiated endocrine carcinoma with a high proliferative index? A case of gastric endocrine carcinoma].
Stefanescu C; Mathieu N; Bouarioua N; Abbey-Toby A; Karila Cohen P; Chosidow D; Soulé JC; Aparicio T
Gastroenterol Clin Biol; 2006 May; 30(5):798-800. PubMed ID: 16801910
[No Abstract] [Full Text] [Related]
2. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
3. Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms.
Brandi G; Paragona M; Campana D; Brighi N; Bondi A; Pantaleo MA; Corbelli J; Barbera MA; Biasco G
J Chemother; 2018 Feb; 30(1):53-58. PubMed ID: 28641483
[TBL] [Abstract][Full Text] [Related]
4. [Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP].
Ohwada S; Miyamoto Y; Takeshita M; Fujii T; Uchida O; Tanahasi Y; Aoyagi H; Izuo M
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3487-9. PubMed ID: 2802641
[No Abstract] [Full Text] [Related]
5. Can Carboplatin replace Cisplatin in small cell lung cancer?
Noronha V
Indian J Cancer; 2011; 48(4):452-3. PubMed ID: 22293259
[No Abstract] [Full Text] [Related]
6. [A case of lymph node recurrence of endocrine cell carcinoma of stomach effectively treated with carboplatin and etoposide].
Ohashi N; Jinno S; Shimokata T; Kobayashi D; Tanaka C; Fujiwara M; Yamada S; Fujii T; Nomoto S; Takeda S; Kodera Y
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2545-8. PubMed ID: 23235176
[TBL] [Abstract][Full Text] [Related]
7. Irinotecan plus cisplatin followed by octreotide long-acting release maintenance treatment in advanced gastroenteropancreatic neuroendocrine carcinoma: IPO-NEC study.
Li J; Lu M; Lu Z; Li Z; Liu Y; Yang L; Li J; Zhang X; Zhou J; Wang X; Gong J; Gao J; Li Y; Shen L
Oncotarget; 2017 Apr; 8(15):25669-25678. PubMed ID: 27788498
[TBL] [Abstract][Full Text] [Related]
8. [Tumor lysis syndrome after chemotherapy for colon small cell carcinoma].
El Mesbahi O; Beaudoin A; Louvet C; De Gramont A
Rev Med Interne; 2004 Oct; 25(10):768-9. PubMed ID: 15471607
[No Abstract] [Full Text] [Related]
9. Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas.
Frizziero M; Spada F; Lamarca A; Kordatou Z; Barriuso J; Nuttall C; McNamara MG; Hubner RA; Mansoor W; Manoharan P; Fazio N; Valle JW
Neuroendocrinology; 2019; 109(2):100-112. PubMed ID: 30703770
[TBL] [Abstract][Full Text] [Related]
10. Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer.
Wilke H; Preusser P; Stahl M; Harstrick A; Meyer HJ; Achterrath W; Schmoll HJ; Seeber S
Cancer Chemother Pharmacol; 1991; 29(1):83-4. PubMed ID: 1742854
[TBL] [Abstract][Full Text] [Related]
11. Toxicity of etoposide, doxorubicin, and cisplatin in gastric cancer.
Sparano JA; Wiernik PH
J Clin Oncol; 1990 May; 8(5):938-9. PubMed ID: 2332775
[No Abstract] [Full Text] [Related]
12. Determining the role of radiotherapy in the adjuvant management of gastric cancer: an ocean apart.
Corn BW; Geva R
Cancer Chemother Pharmacol; 2010 May; 65(6):1005-7. PubMed ID: 20174924
[No Abstract] [Full Text] [Related]
13. Phase-II-study with EAP (etoposide, adriamycin, cis-platinum) in patients with primary inoperable gastric cancer and advanced disease.
Preusser P; Wilke H; Achterrath W; Fink U; Neuhaus P; Meyer J; Meyer HJ; van de Loo J
Recent Results Cancer Res; 1988; 110():198-206. PubMed ID: 3406503
[No Abstract] [Full Text] [Related]
14. High-dose chemotherapy for salvage treatment of germ cell tumors: Charité, Virchow Klinikum, Berlin.
Siegert W; Rick O; Beyer J
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S7-9. PubMed ID: 9916622
[No Abstract] [Full Text] [Related]
15. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
Tscherry G; Jacky E; Jost LM; Stahel RA
Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
[TBL] [Abstract][Full Text] [Related]
16. [Conversion Therapy Using Etoposide and Cisplatin Chemotherapy for Liver Metastases from Advanced Gastric Mixed Adenoneuroendocrine Carcinoma - A Case Report].
Inaba Y; Fujita M; Ninomiya R; Hashimoto D
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1488-1490. PubMed ID: 29394677
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine Cancer, Therapeutic Strategies in G3 Cancers.
Rinke A; Gress TM
Digestion; 2017; 95(2):109-114. PubMed ID: 28161703
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
Bajorin DF; Sarosdy MF; Pfister DG; Mazumdar M; Motzer RJ; Scher HI; Geller NL; Fair WR; Herr H; Sogani P
J Clin Oncol; 1993 Apr; 11(4):598-606. PubMed ID: 8386751
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
Lund B; Hansen OP; Hansen HH; Hansen M
Semin Oncol; 1992 Feb; 19(1 Suppl 1):26-9. PubMed ID: 1411618
[TBL] [Abstract][Full Text] [Related]
20. [Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
Tokunaga A; Onda M; Mizutani T; Miyamoto M; Nomura T; Hayashi H; Kiyama T; Umehara M; Nishi K; Andoh T
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3713-8. PubMed ID: 2596854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
